Turner Rosemary 4

What Happened

• Rosemary Turner, a director of Murphy USA (MUSA), received an award of 421 Restricted Stock Units (RSUs) that vested/settled into shares (reported 02-12-2026). On 02-13-2026 she had derivative securities converted/exercised for 349 shares and those 349 shares were reported as disposed the same day. The transactions are award/settlement and conversion of derivative securities; no cash purchase price was paid (report shows $0.00 per share for these award/conversion items).

Key Details

• Transaction dates: RSU award/settlement reported 2026-02-12; conversion/exercise and disposition reported 2026-02-13. Form 4 filed 2026-02-17.
• Prices/values: All items reported at $0.00 per share (typical for RSU settlements and derivative conversions); no dollar sale proceeds or market value are shown in the provided entries.
• Shares affected: 421 RSUs granted/settled; 349 shares converted/exercised and 349 shares disposed.
• Shares owned after transaction: Not stated in the excerpt provided (filing does not disclose total post-transaction holdings here).
• Footnotes: F1–F4 indicate these were RSUs and accrued dividend equivalents that vested and were settled one-for-one into shares (fractional dividend equivalents paid in cash), granted under the 2023 Omnibus Incentive Plan, and the related securities do not have conversion price/exercise/expiration terms.
• Timeliness: Form 4 was filed on Feb 17, 2026 reporting the Feb 12–13 transactions; the filing shows the transactions and filing date but does not note any late-filing legend in the provided details.

Context

• RSUs are compensation awards that convert to stock on vesting; the conversion/exercise entries reflect settlement of those derivative awards into shares. The subsequent “disposed” entry indicates those converted shares were transferred out of the reporting person’s account on the same day (the filing does not state proceeds or reason such as tax withholding).
• These filings document compensation-related equity settlement rather than an open-market purchase or a straightforward sale by choice; such award settlements are routine for executives and directors and do not by themselves indicate a personal bullish or bearish view.